Cytokinetics, Incorporated (CYTK) vs Protagonist Therapeutics, Inc. (PTGX)

• Cytokinetics, Incorporated CYTK 54.86 ▼ −1.24%
• Protagonist Therapeutics, Inc. PTGX 132.53 ▼ −2.02%

Cytokinetics, Incorporated and Protagonist Therapeutics, Inc. are both Biotechnology companies. Protagonist Therapeutics, Inc. is the larger, with a market value of $8.8B against $7.7B — 1.1× the size. Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 111×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against 29.9%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −686.6%) and the higher return on invested capital (61.8% vs 0.00%). Across the 17 metrics below, Protagonist Therapeutics, Inc. leads on 13 and Cytokinetics, Incorporated on 4.